Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
Clinical trial NCT05556096 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05556096
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-21
- Primary completion
- 2025-05-27
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.